# L-Tyrosine Supplementation in Patients With Fibromyalgia

> **NCT01219049** · NA · TERMINATED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 15 (actual)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** Tyrosine
- **DRUG:** Tyrosine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01219049
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-01
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Due to FDA comments, changes required unavailable resources. There are no results for this study.
- **Last updated:** 2017-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01219049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01219049, "L-Tyrosine Supplementation in Patients With Fibromyalgia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01219049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*